KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Payables (2016 - 2025)

LifeMD's Payables history spans 14 years, with the latest figure at $14.9 million for Q4 2025.

  • For Q4 2025, Payables rose 27.78% year-over-year to $14.9 million; the TTM value through Dec 2025 reached $14.9 million, up 27.78%, while the annual FY2025 figure was $14.9 million, 27.78% up from the prior year.
  • Payables reached $14.9 million in Q4 2025 per LFMD's latest filing, down from $20.3 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $129.2 million in Q1 2024 to a low of $9.5 million in Q1 2023.
  • Average Payables over 5 years is $20.2 million, with a median of $13.9 million recorded in 2021.
  • Peak YoY movement for Payables: soared 2249.07% in 2021, then crashed 87.26% in 2025.
  • A 5-year view of Payables shows it stood at $10.0 million in 2021, then skyrocketed by 36.89% to $13.7 million in 2022, then decreased by 11.71% to $12.1 million in 2023, then dropped by 3.29% to $11.7 million in 2024, then grew by 27.78% to $14.9 million in 2025.
  • Per Business Quant, the three most recent readings for LFMD's Payables are $14.9 million (Q4 2025), $20.3 million (Q3 2025), and $25.1 million (Q2 2025).